Integrating androgen deprivation therapy with metastasis-directed therapy leads to improved progression-free survival – IOSI Oncology Institute of Southern Switzerland – EOC
IOSI Oncology Institute of Southern Switzerland – EOC made the following post on LinkedIn:
“New publication! A collaborative research effort involving physicians from the IOSI Istituto Oncologico della Svizzera Italiana – EOC has now been published in the international journal European Urology Oncology.
The study presents findings from a multicentric retrospective data analysis examining the efficacy of metastasis-directed radiotherapy with or without androgen deprivation therapy in patients with oligometastatic prostate cancer. Remarkably, the research demonstrates that integrating androgen deprivation therapy with metastasis-directed therapy leads to improved progression-free survival. Congratulations Prof. Silke Gillessen, Dr. Davide Bosetti and all authors!
Link to the article.”
Source: IOSI Oncology Institute of Southern Switzerland – EOC/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023